Tag: cancer immunotherapy


  • Nanomedicine Emerges as a Key Tool to Boost Cancer Immunotherapy

    Nanomedicine Emerges as a Key Tool to Boost Cancer Immunotherapy

    Nanomedicine and Immunotherapy: A New Synergy The landscape of cancer treatment is rapidly evolving as researchers explore how nanotechnology can complement and strengthen immunotherapy. Recent back-to-back reviews in Nature Cancer and Trends in Cancer highlight nanomedicine as a versatile approach to reprogram the immune system and overcome the immune evasion strategies employed by solid tumors.…

  • Nanomedicine Boosts Cancer Immunotherapy: Reprogramming the Immune Fight

    Nanomedicine Boosts Cancer Immunotherapy: Reprogramming the Immune Fight

    Nanomedicine Emerges as a Key Tool in Cancer Immunotherapy Researchers at the Fralin Biomedical Research Institute at Virginia Tech (VTC) and their collaborators are exploring how nanotechnology and immunology intersect to enhance cancer immunotherapy. Recent back-to-back review articles published in Nature Cancer and Trends in Cancer synthesize current insights on how nanoengineering can reprogram the…

  • Engineered Salmonella therapy delivers immune payloads to combat cancer

    Engineered Salmonella therapy delivers immune payloads to combat cancer

    Breakthrough in bacterial immunotherapy: ACTM-838 targets solid tumors Solid tumors have long posed a challenge for immunotherapy, often creating an immune-suppressive microenvironment that thwarts even the most advanced treatments. A new study published in Oncotarget (Volume 16, October 6, 2025) introduces ACTM-838, a novel systemically delivered bacterial immunotherapy designed to enrich in solid tumors and…

  • Engineered Salmonella Therapy Delivers Immune Payloads to Fight Cancer

    Engineered Salmonella Therapy Delivers Immune Payloads to Fight Cancer

    New Bacterial Immunotherapy Targets Solid Tumors Researchers have unveiled ACTM-838, a novel, systemically delivered bacterial immunotherapy designed to enrich solid tumors with immune-stimulating payloads. Published in Volume 16 of Oncotarget on October 6, 2025, the study demonstrates how a specially engineered Salmonella Typhimurium strain can safely localize to tumors and deliver potent immune activators directly…

  • Unraveling Tumor-associated Adaptive NK Cells: A Doctoral Disputation by Yizhe Sun

    Unraveling Tumor-associated Adaptive NK Cells: A Doctoral Disputation by Yizhe Sun

    Overview of the disputation The doctoral disputation by Yizhe Sun, held on October 24, 2025, at Karolinska Institutet in Stockholm, marks a significant milestone in tumor immunology. The examination, supervised by senior and junior mentors from Karolinska Institutet and collaborating institutions, centers on the phenotypic features and functional mechanisms of tumor-associated adaptive natural killer (NK)…

  • Zeaxanthin: A Common Nutrient from Veggies Could Boost Cancer Immunity

    Zeaxanthin: A Common Nutrient from Veggies Could Boost Cancer Immunity

    Zeaxanthin: From Eye Health to Immune Enhancement Zeaxanthin is a yellow-orange carotenoid long celebrated for its role in protecting vision. Yet researchers are uncovering a surprising new function for this nutrient: it may help fortify the body’s defense against cancer. Found abundantly in egg yolk and a range of vegetables and fruits—carrots, orange peppers, spinach,…